LL5374-5
Cancer therapies
Active
Basic Properties
- OID
- 1.3.6.1.4.1.12009.10.1.4210
- Name
- Cancer therapies
- Description
- Answers: 7; Scale: Nom; Code: -; Score: -
- LOINCs using this list
- 5
Answer List
| Answer | Code | Score | Answer ID |
|---|---|---|---|
| Binimetinib | LA30251-5 | ||
| Imatinib | LA30253-1 | ||
| Sunitinib | LA30250-7 | ||
| Trametinib | LA30252-3 | ||
| Midostaurin | LA30247-3 | ||
| Sorafenib | LA30248-1 | ||
| Ponatinib | LA30249-9 |
LOINC terms using this Answer List
| 93347-3 | Available treatment related to genetic variant and not to patient diagnosis [Identifier] in Blood or Tissue Nominal |
| 93348-1 | Available treatment related to genetic variant and to patient diagnosis [Identifier] in Blood or Tissue Nominal |
| 93344-0 | Treatment to which genetic variant confers resistance [Identifier] in Blood or Tissue Nominal |
| 93349-9 | Treatment to which interaction between genetic variants confers resistance [Identifier] in Blood or Tissue Nominal |
| 93343-2 | Treatment to which interaction between genetic variants confers synergy [Identifier] in Blood or Tissue Nominal |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LL5374-5 - ValueSet definition
- https:
//fhir.loinc.org/ValueSet/?url=http: //loinc.org/vs/LL5374-5 - ValueSet expansion
- https:
//fhir.loinc.org/ValueSet/$expand?url=http: //loinc.org/vs/LL5374-5
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://